Governor Dannel P. Malloy announced that SCA Pharmaceuticals, an Arkansas-based company, to establish a presence in Connecticut through the creation of a 90,000-square-foot manufacturing facility in Windsor, where the company has plans to create approximately 361 new jobs over the next four years.
SCA manufactures injectable pharmaceuticals in ready-to-administer dosages for use at hospitals and healthcare facilities. The company helps healthcare facilities increase efficiencies and reduce costs while improving patient care.
“The commitment from SCA Pharmaceuticals to choose Connecticut for its expansion reinforces how our strategic location and world-class workforce makes our state a great place for businesses that are looking to bring their operations to the east coast,” Governor Malloy said. “This is an important sector of our economy, and we are thrilled that this company is adding hundreds of good, high-quality jobs in our state.”
Dr. Gene Graves, CEO of SCA, said, “Connecticut represents an ideal location for SCA, driven by its incredible workforce and myriad transportation options.”
SCA is leasing a facility at 755 Rainbow Road in Windsor. The state, through the Department of Economic and Community Development (DECD), will support the project with an $8.5 million loan for leasehold improvements and the purchase of machinery and equipment. The funding will require approval from the state Bond Commission.
“For the past six years, Connecticut has made major investments in manufacturing, bioscience, and workforce development,” Lt. Governor Nancy Wyman said. “These investments position us to attract new business and development, grow jobs, and further establish Connecticut as a global competitor in bioscience and healthcare. I welcome SCA Pharmaceuticals to the state.”